Published September 13, 2013 | Version v1
Journal article Metadata-only

Focal low-dose rate brachytherapy for the treatment of prostate cancer

Creators

  • 1. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY (United States)

Description

Whole-gland low-dose rate (LDR) brachytherapy has been a well-established modality of treating low-risk prostate cancer. Treatment in a focal manner has the advantages of reduced toxicity to surrounding organs. Focal treatment using LDR brachytherapy has been relatively unexplored, but it may offer advantages over other modalities that have established experiences with a focal approach. This is particularly true as prostate cancer is being detected at an earlier and more localized stage with the advent of better detection methods and newer imaging modalities

Availability note (English)

Available from http://dx.doi.org/10.2147/CMAR.S33056; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775638

Additional details

Identifiers

URL
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775638;
DOI
10.2147/CMAR.S33056;

Publishing Information

Journal Title
Cancer Management and Research
Journal Volume
5
Journal Page Range
p. 315-325
ISSN
1179-1322

INIS

Country of Publication
New Zealand
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47001275
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BRACHYTHERAPY; NEOPLASMS; PROSTATE
Descriptors DEC
BODY; DISEASES; GLANDS; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RADIOTHERAPY; THERAPY

Optional Information

Copyright
Copyright (c) 2013 Tong et al, publisher and licensee Dove Medical Press Ltd
Notes
PMCID: PMC3775638; PMID: 24049459; PUBLISHER-ID: cmar-5-315; OAI: oai:pubmedcentral.nih.gov:3775638; This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.